T cell therapies

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

IN8bio Grants Stock Options to New Employees Under Nasdaq Inducement Rules

IN8bio issued 11,800 stock options to two new employees on April 1, 2026, as hiring incentives under Nasdaq listing regulations.
INABautoimmune diseasescancer treatment
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Autolus to Present Pipeline Updates at Spring Healthcare Conferences

Autolus to present pipeline updates and 2025 financial results at two March 2026 healthcare conferences, discussing commercial progress and strategic priorities.
AUTLinvestor conferencebiopharmaceutical